William Downie

Cohance :About Us :Leadership :William Downie
Cohance : About Us : Leadership : William Downie

Advisory Board

Our Board of Directors comprises industry veterans and strategic leaders who guide Cohance’s vision and growth. Their expertise spans pharmaceuticals, private equity, and corporate governance, ensuring we remain a trusted partner in health science innovation.

William Downie

Advisor
William-Downie

William Downie

Advisor

Mr. Will Downie is a globally respected biopharma services executive and two-time CDMO CEO with a proven track record in commercial transformation and value creation.

As CEO of Vectura, he repositioned the company as a leader in inhalation CDMO, doubling its value and leading its strategic sale. At Argenta, he built the world’s top CRO/CDMO in animal health under KKR ownership. As CCO of Catalent, he helped drive its evolution into a top-three global CDMO and supported its transition to a NYSE-listed company.

Currently a Strategic Advisor to Boards and an Operating Partner with a leading private equity firm, he focuses on commercial strategy, transformation, and leadership in the pharma and CDMO industries.